Products

What will AGI do for Almotriptan malate?

This classification denotes a serotonin agonist with the molecular formula C17H25N3O2S.C4H6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PJP312605E, chemically known as 1-(((3-(2-(dimethylamino)ethyl)-1h-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedionate (1:1) but more generally known as almotriptan malate, which bears US NIH Compound Identifier 123607. The base compound, Almotriptan, comes in base and malate forms. European Medicines Agency schedules Almotriptan malate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20534. Most nations, for tariff and trade purposes, schedule almotriptan malate under HS 29350090 and SITC 51580. As of Q4 2014, ALMOTRIPTAN MALATE remains US FDA's Preferred Term for this commodity. Almotriptan malate bears US NLM identifiers UMLS ID C0937898 and NCI Concept Code C61628. SMILES: CN(C)CCC1C[NH]C2C1CC(CC2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Almotriptan malate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Almotriptan malate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Almotriptan malate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Almotriptan malate connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Compound Puritymodel
  • Crystal Form Polymorphmodel
  • Particle Size Distributionmodel
  • Salt Stoichiometrymodel